about the author

Max Bayer

Pharma Reporter

mbayer@endpointsnews.com

author articles

Fed­er­al judge sides with FDA on its mifepri­s­tone safe­ty pro­gram

6 hours ago
FDA+
Law

Trump hints at tar­iff grace pe­ri­od for phar­ma com­pa­nies to bring man­u­fac­tur­ing to US

Yesterday
Pharma
Manufacturing

Clin­i­cian groups sue RFK Jr. and HHS over Covid-19 vac­cine rec­om­men­da­tion changes

2 days ago
R&D
Pharma

FDA re­view­ers ad­vised broad la­bel for Mod­er­na’s next-gen Covid vac­cine. Prasad over­ruled them

Last week
Pharma
FDA+

CDC ex­pands RSV vac­cine rec­om­men­da­tions, sid­ing with pre­vi­ous pan­el of agency ad­vi­sors

Last week
Pharma
FDA+

PBM re­forms fail to make the cut as Sen­ate pass­es Trump’s mega­bill

Last week
R&D
Pharma

Beck­ley touts pos­i­tive mid-stage psy­che­del­ic da­ta fol­low­ing atai merg­er plans

Last week
R&D

Sage plans to lay off al­most every em­ploy­ee af­ter ink­ing Su­per­nus deal

Last week
People
Deals

CBER chief Prasad sug­gests Covid vac­cine harms may out­weigh ben­e­fits in 'low-risk pop­u­la­tion­s'

Last week
R&D
Pharma

Mod­er­na's Phase 3 flu vac­cine ef­fi­ca­cy in line with com­peti­tors, tee­ing up new sub­mis­sions

Last week
R&D
Pharma

De­bate on a long-scru­ti­nized vac­cine in­gre­di­ent con­sumes CDC pan­el in its sec­ond day

Last week
R&D
FDA+

Ex-CBER chief Marks crit­i­cizes how FDA craft­ed its new Covid vac­cine frame­work

2 weeks ago
R&D
Pharma

Re­built CDC pan­el will re­assess cu­mu­la­tive vac­cine ef­fects, old­er shots

2 weeks ago
R&D
FDA+

RFK Jr. says he did not com­mit to up­hold­ing ACIP ros­ter to se­cure Cas­sidy’s back­ing

3 weeks ago
Pharma
FDA+

The pol­i­tics of vac­ci­na­tion take cen­ter stage as RFK Jr.’s re­built CDC pan­el is set to meet

3 weeks ago
FDA+

In­side the FDA’s ‘lis­ten­ing’ tour: Of­fi­cials agree US lags be­hind Chi­na on drug de­vel­op­ment

3 weeks ago
R&D
FDA+

Q&A: New BIO chair to steer in­dus­try through ‘ex­is­ten­tial threats’ de­spite FDA re­cep­tiv­i­ty

3 weeks ago
R&D
China

Fired vac­cine ad­vi­sors de­fend ACIP’s work, in­de­pen­dence in joint ed­i­to­r­i­al

4 weeks ago
R&D
Pharma

Ab­b­Vie’s can­cer drug fails Phase 3 com­bo study to treat oth­er bone mar­row dis­eases

4 weeks ago
R&D
Pharma

Mod­er­na wins ex­pand­ed la­bel for RSV shot, al­low­ing use in at-risk, younger adults

4 weeks ago
Pharma
FDA+

Ex­clu­sive: Kennedy picks for vac­cine ad­vi­so­ry board were paid ex­perts against Mer­ck in civ­il cas­es

4 weeks ago
R&D
Pharma

RFK Jr. names eight new ACIP mem­bers, in­clud­ing pop­u­lar vac­cine crit­ic Robert Mal­one

4 weeks ago
Pharma
FDA+

Trump of­fi­cials seek price de­tails and weigh con­sumer sales as they ex­am­ine most fa­vored na­tion plan

4 weeks ago
Pharma

Fed­er­al of­fi­cials sched­ule three lis­ten­ing ses­sions this sum­mer to ad­dress drug com­pe­ti­tion

4 weeks ago
Pharma
1234 Next page Last page
A service from the Financial Times